Chronic Kidney Disease: Reducing Risks of Progression-- Prismic ... The Herald | HeraldOnline.com SCOTTSDALE, Ariz., June 13, 2013 — /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company, today announced that it has secured exclusive licensing rights to Palmitoylethanolamide (PEA), including the ... |
